China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effect of Biostime BEISHUBI Probiotic Supplement in alleviating allergic rhinitis (AR) in children'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136723
Registration Time: 2026/11/14
Type: Interventional study
Primary Sponsor: Shanghai Sixth People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347140
Published by HT Digital Content Services with permission from Health Daily Digest....